HC Deb 22 February 2000 vol 344 cc910-1W
Mr. Paul Marsden

To ask the Secretary of State for Health what assessment he has made of the effectiveness of hyperbaic oxygen therapy for MS; and if he will make a statement. [110707]

Mr. Denham

There are no current United Kingdom marketing authorisations for hyperbaic oxygen indicated for the treatment of Multiple Sclerosis. Therefore, it is not licensed in the UK as a medicinal product for this purpose and the Medicines Control Agency cannot comment as to its safety, quality and efficacy for this kind of treatment.